Welcome to the Atopic Keratoconjunctivitis Resource Guide
At a Glance
Atopic keratoconjunctivitis (AKC) is a chronic, year-round inflammatory eye disease closely linked to eczema. It causes severe itching, burning, and light sensitivity. Because untreated AKC can lead to permanent vision loss, it requires specialized, long-term management with an eye care specialist.
Receiving a diagnosis of atopic keratoconjunctivitis (AKC) can feel overwhelming, especially when you realize it is more than just a typical case of “itchy eyes.” It is a chronic, bilateral (affecting both eyes), and severe inflammatory disease of the ocular surface [1][2]. Unlike common seasonal allergies that come and go with the pollen count, AKC is perennial, meaning it persists year-round and often continues throughout adulthood [1][2].
If you feel like your symptoms are more intense than those of others with allergies, your experience is valid. AKC is characterized by persistent itching, burning, and tearing that can significantly impair your quality of life [1][3]. Because it carries a risk of permanent vision loss if not managed carefully, it requires specialized, long-term attention from your medical team [4][5].
This resource is designed to help you understand your diagnosis, recognize emergencies, learn about your treatment options, and navigate life with AKC.
The Connection to Your Skin
AKC is closely linked to atopic dermatitis (the most common form of eczema) [1][2]. In many cases, the severity of your eye symptoms is directly related to the severity of your skin condition [6][7]. This is because both conditions share similar underlying immune system pathways involving T-cells (white blood cells that manage immune responses) and cytokines (proteins that signal inflammation) [8][6].
Because of this “skin-eye” connection, patients with AKC often experience blepharitis (inflammation of the eyelids) or dermatitis on the eyelids themselves [2][9]. Managing the systemic (body-wide) inflammation of your eczema is often a critical piece of protecting your ocular health [6].
Three Facts for Navigating Your Diagnosis
It is natural to feel anxious about a condition that could affect your sight. Understanding these three facts can help you stabilize and prepare for the road ahead:
- AKC is manageable, though it is chronic. While AKC is a long-term condition, modern treatments like topical immunomodulators (medications that help regulate the immune response, such as cyclosporine or tacrolimus) are highly effective at controlling inflammation and preventing damage to the eye [10][11].
- It is distinct from “regular” allergies. Standard over-the-counter allergy drops may not be enough because AKC involves deeper layers of the eye. It is characterized by intense symptoms like photophobia (extreme sensitivity to light) and mucous discharge, which result from constant inflammation of the cornea (the clear front window of the eye) [12][4].
- Proactive care protects your vision. The most serious risks of AKC, such as corneal ulcers or keratoconus (a thinning and bulging of the cornea), are often the result of untreated, chronic inflammation [13][14]. By staying consistent with your treatment plan and attending regular check-ups, you and your doctor can monitor for these changes early [4].
Why This Isn’t Just Seasonal
While seasonal allergic conjunctivitis is triggered by specific outdoor allergens, AKC is driven by a more complex immune response that doesn’t “turn off” when the seasons change [2]. It can be exacerbated by environmental factors like air pollution, but the primary driver is your body’s internal immune hyper-reactivity [15][16]. Recognizing AKC as a year-round commitment to eye health is the first step toward long-term stability.
Guide Overview
To learn more about your condition and how to manage it, read through the pages of this guide:
The Biology of AKC and How It Differs from Other Eye Allergies
Learn the biology behind Atopic Keratoconjunctivitis (AKC). Understand how it differs from typical eye allergies, the Th2 response, and the dupilumab paradox.
Treatment Strategy and Standard of Care for AKC
Learn about the stepped approach to atopic keratoconjunctivitis (AKC) treatment. Explore foundational care, steroid-sparing drops, and surgical options.
Protecting Your Corneas and Long-Term Monitoring
Learn how to protect your corneas with atopic keratoconjunctivitis (AKC). Understand keratoconus risks, shield ulcers, IOP monitoring, and when to seek help.
Common questions in this guide
What is atopic keratoconjunctivitis (AKC)?
How is AKC related to eczema?
Can atopic keratoconjunctivitis cause permanent vision loss?
Why don't regular over-the-counter allergy eye drops work for AKC?
Should my dermatologist and ophthalmologist work together to treat my AKC?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How does the severity of my atopic dermatitis directly affect the health of my eyes?
- 2.Since AKC is a perennial condition, what is our long-term plan for managing inflammation throughout the year?
- 3.How should my dermatologist and ophthalmologist coordinate my care to manage both my skin and my eyes?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.
Ridolo E, Kihlgren P, Pellicelli I, et al.
Drugs & aging 2019; (36(7)):581-588 doi:10.1007/s40266-019-00676-7.
PMID: 31055787 - 2
Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.
Li J, Luo X, Ke H, Liang L
Pediatrics 2018; (141(Suppl 5)):S470-S474 doi:10.1542/peds.2016-2069.
PMID: 29610174 - 3
Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents.
Zhang SY, Li J, Liu R, et al.
JAMA ophthalmology 2021; (139(8)):830-837 doi:10.1001/jamaophthalmol.2021.1708.
PMID: 34110380 - 4
Glycomics in tears: seeking for new biomarkers for ocular allergy diagnosis.
Fauquert JL, Kowalski ML
Allergy 2021; (76(8)):2335-2336 doi:10.1111/all.14846.
PMID: 33825208 - 5
Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis.
Jabbehdari S, Starnes TW, Kurji KH, et al.
The ocular surface 2019; (17(2)):303-309 doi:10.1016/j.jtos.2018.12.002.
PMID: 30528292 - 6
Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic Keratoconjunctivitis.
Hansen PM, Utheim TP, Aass HCD, et al.
The ocular surface 2026; doi:10.1016/j.jtos.2026.02.010.
PMID: 41759910 - 7
Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.
Ueta M, Nishigaki H, Komai S, et al.
Immunity, inflammation and disease 2021; (9(4)):1815-1819 doi:10.1002/iid3.536.
PMID: 34547828 - 8
Where eye meets body part 2: uniting allergy pathways in ocular and atopic disease - T cells take the lead.
Borges S, Pereira VA, Chang C, Galor A
Current opinion in allergy and clinical immunology 2025; (25(5)):364-373 doi:10.1097/ACI.0000000000001097.
PMID: 40747966 - 9
Tacrolimus ointment in the management of atopic keratoconjunctivitis.
Benaim D, Tétart F, Bauvin O, et al.
Journal francais d'ophtalmologie 2019; (42(4)):e147-e151 doi:10.1016/j.jfo.2019.02.003.
PMID: 30851973 - 10
Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
Utine CA, Stern M, Akpek EK
Ocular immunology and inflammation 2019; (27(7)):1184-1193 doi:10.1080/09273948.2018.1511811.
PMID: 30189151 - 11
Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases.
Yazu H, Fukagawa K, Shimizu E, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2021; (17(1)):11 doi:10.1186/s13223-021-00513-w.
PMID: 33522964 - 12
Allergic conjunctivitis: current concepts on pathogenesis and management.
Sacchetti M, Abicca I, Bruscolini A, et al.
Journal of biological regulators and homeostatic agents 2018; (32(1 Suppl. 1)):49-60.
PMID: 29552874 - 13
Association between atopic keratoconjunctivitis and the risk of corneal ulcer.
Jan RL, Weng SF, Wang JJ, et al.
The British journal of ophthalmology 2021; (105(12)):1632-1637 doi:10.1136/bjophthalmol-2020-316206.
PMID: 33011686 - 14
Association between atopic keratoconjunctivitis and the risk of keratoconus.
Weng SF, Jan RL, Wang JJ, et al.
Acta ophthalmologica 2021; (99(1)):e54-e61 doi:10.1111/aos.14509.
PMID: 32567209 - 15
Air pollution significantly associated with severe ocular allergic inflammatory diseases.
Miyazaki D, Fukagawa K, Fukushima A, et al.
Scientific reports 2019; (9(1)):18205 doi:10.1038/s41598-019-54841-4.
PMID: 31796815 - 16
Air Pollution, Pollen, and Indoor Exposures in Allergic Conjunctivitis: A Systematic Review.
Martinez-Perez C, Oliveira AP
Life (Basel, Switzerland) 2026; (16(2)) doi:10.3390/life16020271.
PMID: 41752907
This guide is for informational purposes only and does not replace professional medical advice. Always consult your ophthalmologist or dermatologist regarding your specific AKC symptoms and treatment plan.
Get notified when new evidence is published on Atopic keratoconjunctivitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.